NO20081794L - Fremgangsmate for kvantitativ bestemmelse av poloxamere - Google Patents
Fremgangsmate for kvantitativ bestemmelse av poloxamereInfo
- Publication number
- NO20081794L NO20081794L NO20081794A NO20081794A NO20081794L NO 20081794 L NO20081794 L NO 20081794L NO 20081794 A NO20081794 A NO 20081794A NO 20081794 A NO20081794 A NO 20081794A NO 20081794 L NO20081794 L NO 20081794L
- Authority
- NO
- Norway
- Prior art keywords
- poloxamers
- quantitative determination
- relates
- determination
- protein sample
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
- B01J20/28083—Pore diameter being in the range 2-50 nm, i.e. mesopores
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nanotechnology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05108439 | 2005-09-14 | ||
| US71764205P | 2005-09-16 | 2005-09-16 | |
| PCT/EP2006/066383 WO2007031566A1 (en) | 2005-09-14 | 2006-09-14 | Method for the quantitative determination of poloxamers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20081794L true NO20081794L (no) | 2008-04-14 |
Family
ID=37198996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20081794A NO20081794L (no) | 2005-09-14 | 2008-04-11 | Fremgangsmate for kvantitativ bestemmelse av poloxamere |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7866203B2 (pl) |
| EP (1) | EP1951395B1 (pl) |
| KR (1) | KR20080043301A (pl) |
| AU (1) | AU2006290662B2 (pl) |
| CA (1) | CA2612613A1 (pl) |
| CY (1) | CY1112488T1 (pl) |
| EA (1) | EA014585B1 (pl) |
| HK (1) | HK1119614A1 (pl) |
| IL (1) | IL190139A (pl) |
| NO (1) | NO20081794L (pl) |
| PL (1) | PL1951395T3 (pl) |
| WO (1) | WO2007031566A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101343040B1 (ko) * | 2010-12-28 | 2013-12-18 | 주식회사 삼양바이오팜 | 정제된 폴록사머 및 그의 정제방법 |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN111175385B (zh) * | 2018-11-12 | 2023-02-07 | 珠海润都制药股份有限公司 | 一种厄贝沙坦中厄贝沙坦同分异构体检验方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3119740A (en) | 1959-04-13 | 1964-01-28 | Armour Pharma | Process for preparing purified follicle stimulating hormone |
| GB8600245D0 (en) * | 1986-01-07 | 1986-02-12 | Shell Int Research | Preparation of 2-arylpropionic acids |
| IT1206302B (it) | 1987-06-26 | 1989-04-14 | Serono Cesare Ist Ricerca | Ormone follicolo-stimolante urinario |
| DE69031172T2 (de) | 1989-12-22 | 1998-03-12 | Applied Research Systems | Modifikation der endogenen genexpression mit hilfe eines regulatorischen elements mittels homologe rekombination |
| US6306421B1 (en) * | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6663881B2 (en) * | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6491938B2 (en) * | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6685940B2 (en) * | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
| JP3950484B2 (ja) | 1997-06-25 | 2007-08-01 | アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ | ジスルフィド架橋結合した糖タンパク質ホルモン類似体類およびそれらの調製および使用 |
| US6433144B1 (en) * | 1999-01-12 | 2002-08-13 | Viragen, Inc. | Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods |
| WO2001058493A1 (en) | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
| US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| US7157277B2 (en) * | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
| US7125843B2 (en) * | 2001-10-19 | 2006-10-24 | Neose Technologies, Inc. | Glycoconjugates including more than one peptide |
| US7226903B2 (en) * | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
| US7399613B2 (en) * | 2001-10-10 | 2008-07-15 | Neose Technologies, Inc. | Sialic acid nucleotide sugars |
| US7297511B2 (en) * | 2001-10-10 | 2007-11-20 | Neose Technologies, Inc. | Interferon alpha: remodeling and glycoconjugation of interferon alpha |
| US7265084B2 (en) * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| US7265085B2 (en) * | 2001-10-10 | 2007-09-04 | Neose Technologies, Inc. | Glycoconjugation methods and proteins/peptides produced by the methods |
| US7179617B2 (en) * | 2001-10-10 | 2007-02-20 | Neose Technologies, Inc. | Factor IX: remolding and glycoconjugation of Factor IX |
| US7164005B2 (en) * | 2002-10-17 | 2007-01-16 | Alkermes, Inc. | Microencapsulation and sustained release of biologically active polypeptides |
| ATE492292T2 (de) | 2003-04-02 | 2011-01-15 | Ares Trading Sa | Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh, das nichtionische tensid poloxamer 188 und ein antibakterielles mittel |
| WO2004104025A1 (en) * | 2003-05-21 | 2004-12-02 | Ares Trading S.A. | Method of chromatographic analysis of a protein solution |
-
2006
- 2006-09-14 CA CA002612613A patent/CA2612613A1/en not_active Abandoned
- 2006-09-14 AU AU2006290662A patent/AU2006290662B2/en active Active
- 2006-09-14 PL PL06793534T patent/PL1951395T3/pl unknown
- 2006-09-14 US US12/066,799 patent/US7866203B2/en active Active
- 2006-09-14 WO PCT/EP2006/066383 patent/WO2007031566A1/en active Application Filing
- 2006-09-14 KR KR1020087002042A patent/KR20080043301A/ko not_active Application Discontinuation
- 2006-09-14 EP EP06793534A patent/EP1951395B1/en active Active
- 2006-09-14 EA EA200800814A patent/EA014585B1/ru not_active IP Right Cessation
-
2008
- 2008-03-13 IL IL190139A patent/IL190139A/en active IP Right Grant
- 2008-04-11 NO NO20081794A patent/NO20081794L/no not_active Application Discontinuation
- 2008-11-27 HK HK08113009.4A patent/HK1119614A1/xx unknown
-
2012
- 2012-03-14 CY CY20121100259T patent/CY1112488T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7866203B2 (en) | 2011-01-11 |
| EP1951395B1 (en) | 2012-02-29 |
| AU2006290662B2 (en) | 2010-12-23 |
| EA014585B1 (ru) | 2010-12-30 |
| KR20080043301A (ko) | 2008-05-16 |
| US20080190179A1 (en) | 2008-08-14 |
| WO2007031566A1 (en) | 2007-03-22 |
| IL190139A (en) | 2011-11-30 |
| AU2006290662A1 (en) | 2007-03-22 |
| EP1951395A1 (en) | 2008-08-06 |
| IL190139A0 (en) | 2008-08-07 |
| CY1112488T1 (el) | 2015-12-09 |
| CA2612613A1 (en) | 2007-03-22 |
| EA200800814A1 (ru) | 2008-12-30 |
| HK1119614A1 (en) | 2009-03-13 |
| PL1951395T3 (pl) | 2012-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200970231A1 (ru) | СПОСОБ ОЧИСТКИ Fc-СОДЕРЖАЩИХ БЕЛКОВ | |
| CY2016029I2 (el) | Πρωτεϊνες συνδεσης αντιγονου προς προπρωτεϊνη κονβερτασης σουμπτιλισινης κεχιν τυπου 9(pcsk9) | |
| DE602006016589D1 (de) | Neue markierungsstrategien für den empfindlichen nachweis von analyten | |
| EA200901313A1 (ru) | Ингибиторы тирозинкиназы брутона | |
| EA201270553A1 (ru) | Ингибиторы тирозинкиназы брутона | |
| ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
| ATE485359T1 (de) | Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche | |
| DE602006015793D1 (de) | Proteolipidmembran und lipidmembranen-biosensor | |
| DK1951395T3 (da) | Fremgangsmåde til kvantitativ bestemmelse af poloxamerer | |
| EA201171178A1 (ru) | Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов | |
| EA200702193A1 (ru) | Гликозилирование белков | |
| WO2007114986A3 (en) | Cooperative probes and methods of using them | |
| EA201391627A1 (ru) | Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения | |
| EA201000734A1 (ru) | Способ и аппарат для мониторинга пространственного образования фибринового сгустка | |
| DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
| ATE525657T1 (de) | Analytisches einweg-mikroprozessorgerät | |
| WO2006113477A3 (en) | Use of phosphonazo iii for the measurement of calcium, magnesium and sodium in analytical samples | |
| SG171630A1 (en) | Protein detection reagents and methods with dyes and dextrins | |
| NO20081794L (no) | Fremgangsmate for kvantitativ bestemmelse av poloxamere | |
| DE602005007582D1 (de) | In biologischen proben | |
| MY157846A (en) | Process for the purification of fc-containing proteins | |
| GB2522131A (en) | Isotopic labelling of proteins | |
| EA200602088A1 (ru) | Способ стабилизации пептидов | |
| EA200970074A1 (ru) | Химический способ создания давления | |
| ATE443871T1 (de) | Test zum nachweis von pathologischen prionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |